세계의 미생물 발효 기술 시장(2023-2030년)

Title: Global Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Technology (Fed-Batch Fermentation, Solid-State Fermentation, and Continuous Stirred-Tank Reactor), by Application (Antibiotics, Vaccines, Solvents, and Intermediary compounds), and by End-Users (Bio-Pharmaceutical Industries, Food and Feed Industries, CROs and CMOs, and Academic Research Institutes),Forecast Period (2023-2030).

The global microbial fermentation technology market is anticipated to grow at a CAGR of 5.9% during the forecast period (2023-2030). The major factor driving the global microbial fermentation technology market growth includes the rising industrial fermentation, which is used to generate chemicals, materials, biofuels, meals, and medicines. The main purpose in adoption of fermentation technology is to alter the metabolic pathways using cultivation-based or molecular approaches. Fermentation is a common method used by pharmaceutical companies to manufacture recombinant goods such as recombinant proteins, vaccines, and hormones. For instance, in May 2023, Ardra Inc. produces natural food ingredients such as plant-based meat substitutes, health and nutritional additives, and natural preservatives. Ardra produces natural ingredients more sustainably, more affordably, and with reliable supply via precision fermentation technology.

Segmental Outlook

The global microbial fermentation technology market is segmented by technology, application, and end-users. Based on the technology, the market is sub-segmented into fed-batch fermentation, solid-state fermentation, and continuous stirred-tank reactors. Based on the application, the market is sub-segmented into antibiotics, vaccines, solvents, and intermediary compounds. Further, on the basis of end-users, the market is sub-segmented into bio-pharmaceutical industries, food and feed industries, CROs and CMOs, and academic research institutes. Among the end-users, the bio-pharmaceutical industries sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of emerging innovative technologies such as ultrasound, ohmic heating, MEF, PEF, and cold plasma, these have significantly improved the market for fermentation technologies.

The Antibiotic Sub-Segment is Anticipated to Hold a Considerable Share of the Global Microbial Fermentation Technology Market

Among the application, the antibiotic sub-segment is expected to hold a considerable share of the global microbial fermentation technology market. The segmental growth is attributed to the growing influence of global health concerns, pharmaceutical industry investment, the discovery of new strains, advancements in biotechnology, and the increasing need for antibiotics. To boost production capacity, the new facilities and improved processes bring important sustainability improvements for the company. For instance, in February 2023, Evonik Industries AG's Animal Nutrition Company Line, with a larger focus on antimicrobial growth promoters, strives to offer solutions that assure the health and performance of the animal, protect human health, and meet the growing demand for high-quality animal protein globally.

Regional Outlook

The global microbial fermentation technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe. The evolving landscape of the manufacturing of biologics is a major driving factor for the market in the region. The key market players in the region include Ferment.Co, Perfect Day, Geltor, Inc., The EVERY Co. and others.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Microbial Fermentation Technology Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Growing company involvement in biologics research and product development, together with the presence of a sizable number of contract development organizations in the area, are both factors contributing to regional growth. The region's need for microbial fermentation technology would rise as a result of the convergence of the factors affecting biopharmaceutical outsourcing. To address domestic demand, a number of bioprocessing plants are going to be built in China.

The strong regulatory framework is another key factor in shaping the Asia-Pacific market. India, China, Japan continues to make attempts to improve guidelines regarding the promotion, development, approval, and legal practice surrounding biopharmaceutical products. China is the key revenue contributor in the Asia-Pacific region. One of the key factors influencing the Chinese industry is the way biologics manufacturing is changing. The market has grown as a result of growing spending for biopharmaceutical research and development as well as the adoption of incredibly innovative technology for GMP manufacturing.

Market Players Outlook

The major companies serving the global microbial fermentation technology market includes Abolis Biotechnologies, BioVectra Inc., Microbial Discovery Group, Novozymes A/S, TerraVia Holdings, Inc., and others. The market players are considerably contributing to market growth through the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Novus International Inc., a multinational animal feed and health firm, acquired Agrivida Inc. As a result of the acquisition, Novus has control of the patented INTERIUS technology that Agrivida created to embed feed ingredients inside grain.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global microbial fermentation technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Danone S.A.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. F. Hoffmann-La Roche AG.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Koninklijke DSM NV.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Microbial Fermentation Technology Market by Technology Type
  • 4.1.1. Fed-Batch Fermentation
  • 4.1.2. Solid-State Fermentation
  • 4.1.3. Continuous Stirred-Tank Reactor
• 4.2. Global Microbial Fermentation Technology Market by Application
  • 4.2.1. Antibiotics
  • 4.2.2. Vaccines
  • 4.2.3. Solvents
  • 4.2.4. Intermediary compounds
• 4.3. Global Microbial Fermentation Technology Market by End-User
  • 4.3.1. Bio-Pharmaceutical Industries
  • 4.3.2. Food and Feed Industries
  • 4.3.3. CROs and CMOs
  • 4.3.4. Academic Research Institutes

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Abolis Biotechnologies
• 6.2. Biocon Ltd.
• 6.3. BioVectra Inc.
• 6.4. BIOZEEN
• 6.5. CHAIN Biotechnology Ltd.
• 6.6. Corbion N.V.
• 6.7. EKF Diagnostics
• 6.8. EV Biotech B.V.
• 6.9. Lonza Group AG
• 6.10. Microbial Discovery Group
• 6.11. Novozymes A/S.
• 6.12. PILI
• 6.13. TerraVia Holdings, Inc.
• 6.14. Unibio
• 6.15. Wisconsin BioProducts